跳至主要内容
临床试验/DRKS00030633
DRKS00030633招募中不适用

Cerebral amyloid angiopathy and clinical phenotype of Alzheimer's disease: a prospective multimodality imaging study - CAADMI

Klinik für Neurologie Uniklinik RWTH Aachen0 个研究点目标入组 40 人开始时间: 2023年3月21日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
50 Years 至 one(—)
性别
All

入选标准

  • Written declaration of consent from the study participant in the case of capacity to consent

排除标准

  • - Contraindication for MRI examination
  • - Other causes of intracranial haemorrhage or cortical haemosiderosis other than CAA (e.g. acquired or hereditary coagulation or platelet aggregation disorders, intracranial vascular malformations, CNS vasculitis, significant traumatic brain injury).
  • - Hereditary AD or hereditary CAA
  • - Severity of cognitive impairment according to the Global Deterioration Scale >= 5 (GDS; GDS 5 = moderate dementia)
  • - Atypical phenotypic presentation of AD, such as logopenic primary progressive aphasia or posterior cortical atrophy (PCA)

研究者

发起方
Klinik für Neurologie Uniklinik RWTH Aachen

相似试验